Terwey TH

n.cour projects GmbH,Berlin, Germany.

5 papers

ArticleDMT

Inhaled Mebufotenin (GH001) for Adult Patients With Postpartum Depression: A Phase 2a Open-Label Clinical Trial.

Johnson M, Aceves Baldo P, Arbe E +16

Europe PMC2026
Article5-MeO-DMT

GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.

Cubala WJ, Bajbouj M, Bauer M +30

Europe PMC2026
ArticleDMT

Evaluation of the peak experience scale as a rapid assessment tool for the strength of a psychoactive experience with 5-MeO-DMT.

Reckweg JT, Mason NL, Theunissen EL +3

Europe PMC2025
ArticleDMT

A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression.

Reckweg JT, van Leeuwen CJ, Henquet C +6

Europe PMC2023
ArticleDMT

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers.

Reckweg J, Mason NL, van Leeuwen C +3

Europe PMC2021